RecruitingPhase 3NCT06055257
Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible
Studying Osteoradionecrosis of the mandible
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sunnybrook Health Sciences Centre
- Principal Investigator
- Ben Safa, MDSunnybrook Health Sciences Centre
- Intervention
- modified PENTOCLO (mPENTOCLO)(drug)
- Enrollment
- 24 target
- Eligibility
- All sexes
- Timeline
- 2025 – 2027
Study locations (1)
- Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06055257 on ClinicalTrials.gov